Thermo Fisher Scientific Inc. (TMO) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Diagnostics & Research secteur d'activité. Le siège social de l'entreprise est situé à Waltham, MA, United States. Le PDG actuel est Marc N. Casper.
TMO a date d'introduction en bourse 1980-03-17, 125,000 employés à temps plein, cotée sur le NYSE, une capitalisation boursière de $195.85B.
Thermo Fisher Scientific Inc. is a global life sciences company headquartered in Waltham, Massachusetts, providing comprehensive solutions across analytical instruments, specialty diagnostics, and laboratory products for pharmaceutical, biotechnology, academic, and clinical markets worldwide. The company operates through four main segments: Life Sciences Solutions, which offers reagents and instruments for drug discovery and vaccine production; Analytical Instruments, providing testing equipment for research and industrial applications; Specialty Diagnostics, delivering immunodiagnostic systems and clinical testing solutions; and Laboratory Products and Biopharma Services, supporting pharmaceutical development and clinical research. Thermo Fisher serves customers across North America, Europe, Asia-Pacific, and internationally through its portfolio of leading brands including Thermo Scientific, Applied Biosystems, Invitrogen, and Fisher Scientific, distributing products via direct sales, e-commerce, and third-party partners. Founded in 1956, the company has established itself as a critical infrastructure provider enabling scientific advancement and healthcare innovation globally.
